MX2012012826A - Formulaciones de galactomanana oftalmicas estabilizadas. - Google Patents
Formulaciones de galactomanana oftalmicas estabilizadas.Info
- Publication number
- MX2012012826A MX2012012826A MX2012012826A MX2012012826A MX2012012826A MX 2012012826 A MX2012012826 A MX 2012012826A MX 2012012826 A MX2012012826 A MX 2012012826A MX 2012012826 A MX2012012826 A MX 2012012826A MX 2012012826 A MX2012012826 A MX 2012012826A
- Authority
- MX
- Mexico
- Prior art keywords
- formulations
- stabilized ophthalmic
- guar
- galactomannan formulations
- ophthalmic galactomannan
- Prior art date
Links
- 238000009472 formulation Methods 0.000 title abstract 5
- 239000000203 mixture Substances 0.000 title abstract 5
- 229920000926 Galactomannan Polymers 0.000 title abstract 2
- OMDQUFIYNPYJFM-XKDAHURESA-N (2r,3r,4s,5r,6s)-2-(hydroxymethyl)-6-[[(2r,3s,4r,5s,6r)-4,5,6-trihydroxy-3-[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]methoxy]oxane-3,4,5-triol Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O[C@H]2[C@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@H](O)[C@H](O)O1 OMDQUFIYNPYJFM-XKDAHURESA-N 0.000 title 1
- -1 hydroxypropyl Chemical group 0.000 abstract 3
- 244000007835 Cyamopsis tetragonoloba Species 0.000 abstract 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 abstract 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 abstract 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 abstract 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 abstract 1
- 239000004327 boric acid Substances 0.000 abstract 1
- 150000002009 diols Chemical class 0.000 abstract 1
- 238000012377 drug delivery Methods 0.000 abstract 1
- 229910001629 magnesium chloride Inorganic materials 0.000 abstract 1
- 239000000600 sorbitol Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/736—Glucomannans or galactomannans, e.g. locust bean gum, guar gum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/04—Artificial tears; Irrigation solutions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Biochemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US33151110P | 2010-05-05 | 2010-05-05 | |
| PCT/US2011/035165 WO2011140203A2 (en) | 2010-05-05 | 2011-05-04 | Stabilized ophthalmic galactomannan formulations |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2012012826A true MX2012012826A (es) | 2013-01-28 |
Family
ID=44626461
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2012012826A MX2012012826A (es) | 2010-05-05 | 2011-05-04 | Formulaciones de galactomanana oftalmicas estabilizadas. |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US20110275593A1 (https=) |
| EP (1) | EP2566447B1 (https=) |
| JP (1) | JP5794744B2 (https=) |
| KR (2) | KR20180001587A (https=) |
| CN (2) | CN106389325A (https=) |
| AR (1) | AR081015A1 (https=) |
| AU (1) | AU2011248129B2 (https=) |
| BR (1) | BR112012028308B1 (https=) |
| CA (1) | CA2798069C (https=) |
| ES (1) | ES2809304T3 (https=) |
| MX (1) | MX2012012826A (https=) |
| NZ (1) | NZ603345A (https=) |
| SG (2) | SG10201804305SA (https=) |
| TW (1) | TWI606841B (https=) |
| WO (1) | WO2011140203A2 (https=) |
| ZA (1) | ZA201208199B (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BRPI0910717A2 (pt) * | 2008-04-26 | 2015-09-29 | Alcon Res Ltd | sistema polimérico de lágrima artificial |
| TWI492769B (zh) * | 2009-09-23 | 2015-07-21 | Alcon Res Ltd | 可注射的水性眼用組成物及其使用之方法 |
| TW201336527A (zh) * | 2012-02-10 | 2013-09-16 | Alcon Res Ltd | 具增強的穩定性之水性藥學組成物 |
| UA113434C2 (uk) * | 2012-05-04 | 2017-01-25 | Алкон Рісерч, Лтд. | Офтальмологічна композиція з поліпшеним захистом від зневоднювання й утриманням |
| AR106018A1 (es) | 2015-08-26 | 2017-12-06 | Achillion Pharmaceuticals Inc | Compuestos de arilo, heteroarilo y heterocíclicos para el tratamiento de trastornos médicos |
| WO2017035408A1 (en) | 2015-08-26 | 2017-03-02 | Achillion Pharmaceuticals, Inc. | Compounds for treatment of immune and inflammatory disorders |
| SG11201811491YA (en) | 2016-06-27 | 2019-01-30 | Achillion Pharmaceuticals Inc | Quinazoline and indole compounds to treat medical disorders |
| US11583496B2 (en) | 2016-10-12 | 2023-02-21 | PS Therapy Inc. | Drug vehicle compositions and methods of use thereof |
| US11260035B2 (en) | 2016-10-12 | 2022-03-01 | Ps Therapies Ltd | Topical compositions and methods of use thereof |
| WO2018071619A1 (en) * | 2016-10-12 | 2018-04-19 | Ps Therapies Ltd | Artificial tear, contact lens and drug vehicle compositions and methods of use thereof |
| CN110603252A (zh) | 2017-03-01 | 2019-12-20 | 艾其林医药公司 | 用于治疗医学障碍的芳基、杂芳基和杂环药物化合物 |
| US20230022157A1 (en) | 2018-08-20 | 2023-01-26 | Achillion Pharmaceuticals, Inc. | Pharmaceutical compounds for the treatment of complement factor d medical disorders |
| JP7443375B2 (ja) | 2018-09-06 | 2024-03-05 | アキリオン ファーマシューティカルズ， インコーポレーテッド | 医学的障害の治療のための大環状化合物 |
| EP3866773B1 (en) | 2018-10-16 | 2024-08-28 | Georgia State University Research Foundation, Inc. | Carbon monoxide prodrugs for the treatment of medical disorders |
| TWI757773B (zh) * | 2019-06-28 | 2022-03-11 | 瑞士商愛爾康公司 | 眼用組成物 |
| CN115362162A (zh) | 2020-02-20 | 2022-11-18 | 艾其林医药公司 | 用于治疗补体因子d介导的障碍的杂芳基化合物 |
| CN116437913A (zh) | 2020-09-23 | 2023-07-14 | 艾其林医药公司 | 用于治疗补体介导的病症的药物化合物 |
| WO2025186703A1 (en) | 2024-03-04 | 2025-09-12 | Alcon Inc. | Carbamoylphenylboronic acid-containing acrylic monomers and uses thereof |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8028A (en) * | 1851-04-08 | Hokse-poweb | ||
| US4136173A (en) * | 1977-01-31 | 1979-01-23 | American Home Products Corp. | Mixed xanthan gum and locust beam gum therapeutic compositions |
| DE3827561C1 (https=) * | 1988-08-13 | 1989-12-28 | Lts Lohmann Therapie-Systeme Gmbh & Co Kg, 5450 Neuwied, De | |
| US5505953A (en) * | 1992-05-06 | 1996-04-09 | Alcon Laboratories, Inc. | Use of borate-polyol complexes in ophthalmic compositions |
| DE69839355T2 (de) * | 1997-07-29 | 2009-06-04 | Alcon Laboratories, Inc., Fort Worth | Ophthalmische Zusammensetzungen enthaltend Galaktomannanpolymere und Borat |
| GB9808461D0 (en) * | 1998-04-22 | 1998-06-17 | Innovative Tech Ltd | Solid borate-diol interaction products |
| US7084130B2 (en) * | 2001-12-11 | 2006-08-01 | Alcon, Inc. | Intraocular irrigating solution having improved flow characteristics |
| TWI336257B (en) * | 2003-06-13 | 2011-01-21 | Alcon Inc | Ophthalmic compositions containing a synergistic combination of three polymers |
| US20100021561A1 (en) * | 2006-09-21 | 2010-01-28 | Chowhan Masood A | Self-preserved aqueous pharmaceutical compositions |
| TWI434926B (zh) | 2006-12-11 | 2014-04-21 | Alcon Res Ltd | 眼用組成物中聚氧化乙烯-聚氧化丁烯（ｐｅｏ-ｐｂｏ）嵌段共聚物之使用 |
| AR066901A1 (es) * | 2007-05-18 | 2009-09-23 | Alcon Mfg Ltd | Composiciones fodfolipidicas para elcuidado de lentes de contacto y conservacion de composiciones farmaceuticas |
| BRPI0910717A2 (pt) * | 2008-04-26 | 2015-09-29 | Alcon Res Ltd | sistema polimérico de lágrima artificial |
| EP2393837A1 (en) | 2009-02-05 | 2011-12-14 | Alcon Research, Ltd. | Process for purifying guar |
-
2011
- 2011-05-04 CA CA2798069A patent/CA2798069C/en active Active
- 2011-05-04 US US13/100,439 patent/US20110275593A1/en not_active Abandoned
- 2011-05-04 WO PCT/US2011/035165 patent/WO2011140203A2/en not_active Ceased
- 2011-05-04 BR BR112012028308-1A patent/BR112012028308B1/pt active IP Right Grant
- 2011-05-04 KR KR1020177037138A patent/KR20180001587A/ko not_active Ceased
- 2011-05-04 MX MX2012012826A patent/MX2012012826A/es active IP Right Grant
- 2011-05-04 AU AU2011248129A patent/AU2011248129B2/en active Active
- 2011-05-04 TW TW100115587A patent/TWI606841B/zh active
- 2011-05-04 KR KR1020127031590A patent/KR20130060228A/ko not_active Ceased
- 2011-05-04 NZ NZ603345A patent/NZ603345A/en not_active IP Right Cessation
- 2011-05-04 SG SG10201804305SA patent/SG10201804305SA/en unknown
- 2011-05-04 JP JP2013509217A patent/JP5794744B2/ja active Active
- 2011-05-04 CN CN201610986410.7A patent/CN106389325A/zh active Pending
- 2011-05-04 SG SG2012081386A patent/SG185422A1/en unknown
- 2011-05-04 ES ES11720357T patent/ES2809304T3/es active Active
- 2011-05-04 EP EP11720357.0A patent/EP2566447B1/en active Active
- 2011-05-04 CN CN2011800292803A patent/CN102939074A/zh active Pending
- 2011-05-05 AR ARP110101556A patent/AR081015A1/es unknown
-
2012
- 2012-10-31 ZA ZA2012/08199A patent/ZA201208199B/en unknown
-
2013
- 2013-05-13 US US13/892,429 patent/US8846641B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| NZ603345A (en) | 2014-12-24 |
| KR20180001587A (ko) | 2018-01-04 |
| ES2809304T3 (es) | 2021-03-03 |
| EP2566447B1 (en) | 2020-07-15 |
| WO2011140203A3 (en) | 2012-04-19 |
| CN106389325A (zh) | 2017-02-15 |
| SG10201804305SA (en) | 2018-06-28 |
| AU2011248129A1 (en) | 2012-11-29 |
| CA2798069C (en) | 2016-07-05 |
| BR112012028308B1 (pt) | 2021-09-28 |
| TW201141524A (en) | 2011-12-01 |
| SG185422A1 (en) | 2012-12-28 |
| US20110275593A1 (en) | 2011-11-10 |
| EP2566447A2 (en) | 2013-03-13 |
| CN102939074A (zh) | 2013-02-20 |
| AR081015A1 (es) | 2012-05-30 |
| JP5794744B2 (ja) | 2015-10-14 |
| JP2013525493A (ja) | 2013-06-20 |
| US8846641B2 (en) | 2014-09-30 |
| WO2011140203A2 (en) | 2011-11-10 |
| KR20130060228A (ko) | 2013-06-07 |
| TWI606841B (zh) | 2017-12-01 |
| ZA201208199B (en) | 2014-01-29 |
| CA2798069A1 (en) | 2011-11-10 |
| US20130244971A1 (en) | 2013-09-19 |
| AU2011248129B2 (en) | 2014-10-09 |
| BR112012028308A2 (pt) | 2016-11-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2012012826A (es) | Formulaciones de galactomanana oftalmicas estabilizadas. | |
| MX2013002422A (es) | Sales de lorcaserina con acidos opticamente activos. | |
| IN2014MN02248A (https=) | ||
| MX344473B (es) | Composicion farmaceutica acuosa semisolida que contiene tapentadol. | |
| GB201106743D0 (en) | Novel compounds | |
| ZA201301155B (en) | Ophthalmic drug delivery | |
| GB201106750D0 (en) | Novel compounds | |
| PH12013501136A1 (en) | Lysophosphatidic acid receptor antagonists and uses thereof | |
| MX348823B (es) | Formulaciones estables de linaclotida. | |
| WO2013067199A3 (en) | Subcutaneous delivery of polymer conjugates of therapeutic agents | |
| TN2012000261A1 (en) | Aerosol formulation for copd | |
| WO2013171764A3 (en) | Ophthalmic formulations | |
| IL227352A0 (en) | A system for ocular administration of a drug | |
| PT2591785T (pt) | Utilização de 5-androstano(alquilo)-3,5,6-triol na preparação de fármacos neuroprotetores | |
| MX2014004210A (es) | Derivados de 2-oxo-piperidinilo. | |
| BR112015014137A2 (pt) | unidade sólida com alto teor de fexofenadina e processo para a preparação da mesma | |
| MX2012006265A (es) | Formulaciones disacaridas hipersulfatadas. | |
| GEP20166459B (en) | Ophthalmic solution containing hyaluronic acid or salt thereof and propylene glycol | |
| MX367773B (es) | Forma salina sólida de la alfa-6-mpeg6-o-hidroxicodona como agonistas opioides y sus usos. | |
| MX2012012978A (es) | Metodo para producir pleurodesis. | |
| BR112012020828A2 (pt) | preparado farmacêutico que contém miramistina | |
| GB201110632D0 (en) | Drug delivery formulations | |
| WO2013083226A8 (de) | Porenarmes, wasserfreies natriumcarbonat | |
| CO7141425A2 (es) | Composiciones oftálmicas con retención y protección de desecación mejoradas | |
| UA96649C2 (ru) | Применение глюкозамина гидрохлорида как средства фригопротекторной действия |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |